Learn More
Medchemexpress LLC TAK-285 | 871026-44-7 | C26H25ClF3N5O3 | 100 MG

Supplier: Medchemexpress LLC HY15196100MG
TAK-285 is a potent, selective, ATP-competitive, and orally active HER2 and EGFR (HER1) inhibitor. It demonstrates effective antitumor activity and can cross the blood-brain barrier (BBB). This compound exhibits significant growth inhibitory activity against BT-474 cells.
- Potent and selective HER2 and EGFR (HER1) inhibitor
- IC50 values of 17 nM for HER2 and 23 nM for EGFR (HER1)
- Shows over 10-fold selectivity for HER1/2 compared to HER4
- Less potent against MEK1/5, c-Met, Aurora B, Lck, and CSK
- Demonstrates effective antitumor activity
- Can cross the blood-brain barrier (BBB)
- Exhibits significant growth inhibitory activity against BT-474 cells with a GI50 of 17 nM
- Inhibits MEK1, MEK5, c-Met, Aurora B, Lck, CSK, and Lyn B with varying IC50s
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.